We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is a Thecoma?

By Stephany Seipel
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

A thecoma, also known as a theca cell tumor, is classified as an ovarian sex cord stromal tumor. This type of tumor is relatively rare. Thecomas compromise only around 1 percent of all ovarian tumors.

The ovaries produce theca cells, endocrine cells that control the production of androgen hormones. Pure thecoma tumors are composed of theca cells. The tumors are usually a yellowish or orange color with a well-defined shape and a rigid, inflexible consistency. They grow to between 0.25 inch and 0.31 inch (between 7 cm and 8 cm) on average, but their size varies widely depending on the patient. Theca cell tumors often contain droplets of fat and a jelly-like liquid called cytoplasm.

Typical thecomas usually affect women around menopause, and women between the ages of 50 and 60 years old are in the highest risk category. More than 90 percent of all thecomas are unilateral, or only affect one side, but they occasionally form on both ovaries. They are benign in most cases. Once in a while a thecoma tumor will turn out to be malignant. Malignant tumors usually contain granulosas, which are a different type of ovarian cell, as well as theca cells.

Thecomas usually produce estrogen. Some women who develop thecomas experience symptoms such as irregular menstruation or post-menopausal spotting or bleeding because of excess estrogen production. Other thecoma tumors produce androgens, which are male hormones that are produced in the female adrenal glands and the ovaries. Younger women — those under 30 — are susceptible to luteinizing thecomas, which are a type of tumor that contains steroid cells. A rare type of thecoma, called a Sertoli-Leydig tumor, produces testosterone, so women with this type of thecoma may develop masculine characteristics such as a deepening voice and excess facial hair.

Treatment options include complete hysterectomy, which removes the uterus and ovaries; surgical oophorectomy, or removal of the ovary; and salpingo-oophorectomy, or removal of the fallopian tube and ovary. These surgeries are generally curative, because they remove the hormone-producing tumor. Younger women who want to become pregnant at some point can opt for a wedge resection surgery, which only removes part of the ovarian tissue to limit the amount of hormones that are being produced. Physicians often recommend more radical surgeries for women who have granulosa cells mixed in with thecoma tumors, because this type of tumor occasionally becomes malignant. Many of the symptoms of excessive hormones clear up within several months after surgery.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.